From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors (Q38040128)

27 August 2017

title

From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors (English)

1 reference

27 August 2017

0 references

1 reference

Christos Andronis

0 references

Spyros N Deftereos

1 reference

27 August 2017

Evie Dodou

series ordinal

1 reference

27 August 2017

Aris Persidis

series ordinal

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

Expert Review of Clinical Pharmacology

27 August 2017

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

413-425

1 reference

MAO inhibitors: Risks, benefits, and lore

27 August 2017

cites work

1 reference

Clinical pharmacology of MAO inhibitors: safety and future

21 January 2018

1 reference

The discovery of antidepressants: a winding path

21 January 2018

1 reference

Invited review: the evolution of antidepressant mechanisms

21 January 2018

1 reference

Pirlindole in the treatment of depression and fibromyalgia syndrome

21 January 2018

1 reference

Pirlindole in the treatment of depression: a meta-analysis.

21 January 2018

1 reference

Moclobemide: Therapeutic Use and Clinical Studies

21 January 2018

1 reference

Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects

21 January 2018

1 reference

MAO-inhibitors in Parkinson's Disease

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics

21 January 2018

1 reference

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

21 January 2018

1 reference

Drug repurposing and adverse event prediction using high-throughput literature analysis

21 January 2018

1 reference

Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury

21 January 2018

1 reference

Monoamine oxidase (MAO) in human peripheral tissues

21 January 2018

1 reference

Tissue distribution of human monoamine oxidase A and B mRNA.

21 January 2018

1 reference

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties

21 January 2018

1 reference

Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects

21 January 2018

1 reference

Monoamine oxidases of the human brain and liver

21 January 2018

1 reference

Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves.

21 January 2018

1 reference

Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization

21 January 2018

1 reference

Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors

21 January 2018

1 reference

Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs

21 January 2018

1 reference

Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures

21 January 2018

1 reference

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

21 January 2018

1 reference

VEGF-integrin interplay controls tumor growth and vascularization.

21 January 2018

1 reference

Structure and mechanism of monoamine oxidase

21 January 2018

1 reference

Transcriptional regulation and multiple functions of MAO genes

21 January 2018

1 reference

Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A

21 January 2018

1 reference

Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population

21 January 2018

1 reference

Association of Positive and Negative Parenting Behavior with Childhood ADHD: Interactions with Offspring Monoamine Oxidase A (MAO-A) Genotype

21 January 2018

1 reference

Association analyses of MAOA in Chinese Han subjects with attention-deficit/hyperactivity disorder: family-based association test, case-control study, and quantitative traits of impulsivity

21 January 2018

1 reference

MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders

21 January 2018

1 reference

Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese population

21 January 2018

1 reference

Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder

21 January 2018

1 reference

High activity-related allele of MAO-A gene associated with depressed suicide in males

21 January 2018

1 reference

A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder

21 January 2018

1 reference

Novel monoamine oxidase A knock out mice with human-like spontaneous mutation

21 January 2018

1 reference

Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice

21 January 2018

1 reference

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

21 January 2018

1 reference

Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese

21 January 2018

1 reference

Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans

21 January 2018

1 reference

Polymorphism in environment responsive genes and association with Parkinson disease

21 January 2018

1 reference

The monoamine oxidase B gene exhibits significant association to ADHD.

21 January 2018

1 reference

Platelet monoamine oxidase activity in alcoholics, alcoholics with drug dependence, and cocaine addicts

21 January 2018

1 reference

Increased stress response and β–phenylethylamine in MAOB–deficient mice

21 January 2018

1 reference

Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice

21 January 2018

1 reference

Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants

21 January 2018

1 reference

Treatment of depression with atypical features: a meta-analytic approach

21 January 2018

1 reference

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives

21 January 2018

1 reference

Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial

21 January 2018

1 reference

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

21 January 2018

1 reference

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study

21 January 2018

1 reference

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study

21 January 2018

1 reference

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

21 January 2018

1 reference

Discordant effects of rasagiline doses in Parkinson disease

21 January 2018

1 reference

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials

21 January 2018

1 reference

New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart.

21 January 2018

1 reference

Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats.

21 January 2018

1 reference

Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload

21 January 2018

1 reference

Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury

21 January 2018

1 reference

The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation

21 January 2018

1 reference

Studies on the nature of the antagonistic actions of dopamine and 5-hydroxytryptamine in renal tissues.

21 January 2018

1 reference

Increased renal dopamine and acute renal adaptation to a high-phosphate diet

21 January 2018

1 reference

The renal monoamine oxidases: pathophysiology and targets for therapeutic intervention

21 January 2018

1 reference

Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial

21 January 2018

1 reference

The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

21 January 2018

1 reference

Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.

21 January 2018

1 reference

Selegiline transdermal system (STS) as an aid for smoking cessation

21 January 2018

1 reference

Protection against Parkinson's disease progression: clinical experience

21 January 2018

1 reference

MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography

21 January 2018

1 reference

Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties

21 January 2018

1 reference

Some observations upon a new inhibitor of monoamine oxidase in brain tissue

21 January 2018

1 reference

Synthesis and Anticonvulsant Activity of a New Class of 2-[(Arylalkyl)amino]alkanamide Derivatives

21 January 2018

1 reference

Safinamide: from molecular targets to a new anti-Parkinson drug

21 January 2018

1 reference

A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor

21 January 2018

1 reference

Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits

21 January 2018

1 reference

Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy

21 January 2018

1 reference

Tyramine-induced vasodilation mediated by dopamine contamination: a paradox resolved

21 January 2018

1 reference

Tyramine in foods and monoamine oxidase inhibitor drugs: A crossroad where medicine, nutrition, pharmacy, and food industry converge

21 January 2018

1 reference

Orthostatic side effects of clomipramine and moclobemide during treatment for depression

21 January 2018

1 reference

Antidepressants and falls in the elderly

21 January 2018

1 reference

Modification of sexual functions by antidepressants

21 January 2018

1 reference

Monoamine oxidase inhibitors. A perspective on their use in the elderly

21 January 2018

1 reference

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects

21 January 2018

1 reference

Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer’s disease

21 January 2018

1 reference

Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECP.12.29

1 reference

27 August 2017

1 reference